152 related articles for article (PubMed ID: 29994804)
21. Impact of Multivessel Coronary Artery Disease With Versus Without Left Main Coronary Artery Disease on Long-Term Mortality After Coronary Bypass Grafting Versus Drug-Eluting Stent Implantation.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
Am J Cardiol; 2017 Jan; 119(2):225-230. PubMed ID: 28029362
[TBL] [Abstract][Full Text] [Related]
22. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
[TBL] [Abstract][Full Text] [Related]
23. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
[TBL] [Abstract][Full Text] [Related]
26. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
[TBL] [Abstract][Full Text] [Related]
28. Coronary revascularization in diabetic patients: off-pump versus on-pump surgery.
Renner A; Zittermann A; Aboud A; Pühler T; Hakim-Meibodi K; Quester W; Tschoepe D; Börgermann J; Gummert JF
Ann Thorac Surg; 2013 Aug; 96(2):528-34. PubMed ID: 23791161
[TBL] [Abstract][Full Text] [Related]
29. Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery.
Razzouk L; Feit F; Farkouh ME
Curr Cardiol Rep; 2017 May; 19(5):37. PubMed ID: 28374179
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.
Gao F; Zhou YJ; Shen H; Wang ZJ; Yang SW; Liu XL
Acta Diabetol; 2013 Oct; 50(5):765-73. PubMed ID: 22907763
[TBL] [Abstract][Full Text] [Related]
32. Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus.
Aronson D; Edelman ER
Curr Opin Pharmacol; 2012 Apr; 12(2):134-41. PubMed ID: 22325857
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: a meta-analysis.
Zhang F; Yang Y; Hu D; Lei H; Wang Y
Diabetes Res Clin Pract; 2012 Aug; 97(2):178-84. PubMed ID: 22513345
[TBL] [Abstract][Full Text] [Related]
34. Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.
Giustino G; Dangas GD
Prog Cardiovasc Dis; 2015; 58(3):306-15. PubMed ID: 26255239
[TBL] [Abstract][Full Text] [Related]
35. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
[TBL] [Abstract][Full Text] [Related]
37. Optimal revascularization in diabetes after the FREEDOM trial: were the controversies finally settled?
Tenenbaum A; Fisman EZ
Cardiol J; 2013; 20(4):331-6. PubMed ID: 23913450
[TBL] [Abstract][Full Text] [Related]
38. Very Long-Term (10 to 14 Year) Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era.
Shiomi H; Yamaji K; Morimoto T; Shizuta S; Nakatsuma K; Higami H; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T
Circ Cardiovasc Interv; 2016 Aug; 9(8):. PubMed ID: 27512087
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of adjusted risk estimates for survival from observational studies of complete versus incomplete revascularization in patients with multivessel disease undergoing coronary artery bypass grafting.
Takagi H; Watanabe T; Mizuno Y; Kawai N; Umemoto T;
Interact Cardiovasc Thorac Surg; 2014 May; 18(5):679-82. PubMed ID: 24532310
[TBL] [Abstract][Full Text] [Related]
40. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
